Pacira BioSciences
PCRX
PCRX
283 hedge funds and large institutions have $2.82B invested in Pacira BioSciences in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 106 increasing their positions, 105 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 48
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
84% less call options, than puts
Call options by funds: $2.43M | Put options by funds: $15.1M
Holders
283
Holding in Top 10
5
Calls
$2.43M
Puts
$15.1M
Top Buyers
| 1 | +$41.7M | |
| 2 | +$24.2M | |
| 3 | +$17M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$9.49M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$8.63M |
Top Sellers
| 1 | -$29M | |
| 2 | -$23.9M | |
| 3 | -$13.7M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$10.8M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$10M |